Loading...
OTCM
HMGN
Market cap3kUSD
Aug 26, Last price  
0.00USD
Name

Hemagen Diagnostics Inc

Chart & performance

D1W1MN
OTCM:HMGN chart
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-7.08%
Revenues
4m
-21.38%
1,800,0002,400,0004,000,00010,100,00013,000,00012,400,00014,600,00010,995,60410,970,5589,499,5328,472,7117,470,6777,585,6544,775,2164,487,2366,374,7995,418,9285,220,1705,141,2264,042,094
Net income
-907k
L+3.05%
-1,300,000-1,100,000-1,000,000-500,000400,0000-5,200,000-5,130,136-2,198,821-1,760,483-1,265,269-3,599,168-1,337,249312,926-849,931427,163-808,148-156,314-880,476-907,315
CFO
-359k
L+6.38%
-900,000-400,000-600,000500,000-200,000400,000300,000-1,942,98160,48318,814458,825-165,525-475,263-737,050-482,241265,45016,817-183,179-337,168-358,687

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.

Key people

William Hales
Chairman of the Board, President, Chief Executive Officer · since 2004
M. Robert Campbell
Chief Financial Officer · since 2013
Catherine Davidson
Principal Accounting Officer, Controller · since 2013
Alan Cohen
Independent Director · since 1993
Edward Lutz
Independent Director · since 2004
IPO date
Feb 04, 1993
Employees
15
Domiciled in
US
Incorporated in
US

Valuation

No data to show